Medical Device Network on MSN

Abbott touts neuromodulation portfolio’s long-term benefits

Abbott’s five-year data highlighted neuromodulation therapies’ role in reducing healthcare and patient burdens associated ...
Business Wire

St. Jude Medical Announces US Launch and First Commercial Implants of DRG Stimulation Therapy

Availability of the dorsal root ganglion (DRG) therapy represents an important milestone in the treatment of chronic intractable pain conditions due to complex regional pain syndrome I and II ST. PAUL ...
Tyler Morning Telegraph

SynerFuse™ & Velentium Medical Partnering to Scale Integrated Spinal Fusion & Direct Nerve Stimulation Procedure

EDEN PRAIRIE, Minn., March 21, 2025 /PRNewswire/ — To follow up on the completion of its clinical proof-of-concept study, SynerFuse™ and its partner, Velentium Medical, today announced plans to scale ...
Science Daily

Pain disruption therapy treats source of chronic back pain

People with treatment-resistant back pain may get significant and lasting relief with dorsal root ganglion (DRG) stimulation therapy, an innovative treatment that short-circuits pain, a new study ...
Hosted on MSN

Abbott launches delivery system for electrode implantation process

Abbott has launched a “next-generation” delivery system to streamline the electrode implantation process for its Proclaim DRG neurostimulation system. This advancement aims to improve treatments for ...
Business Wire

Stimwave Announces Completion of Enrollment of the Tsunami Placebo-Controlled Double-Blind Randomized Clinical Study of Wireless DRG Stimulation for Chronic Back Pain

POMPANO BEACH, Fla.--(BUSINESS WIRE)--Stimwave Technologies, the leading innovator of wireless medical device bioelectronic technology, today announced completion of patient enrollment and preliminary ...